TRINIDAD LUCÍA
CEA SORIANO
Profesora titular de universidad
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (8)
2021
-
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
Cardiovascular Diabetology, Vol. 20, Núm. 1
2020
-
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 1, pp. 27-35
-
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 7, pp. 606-615
2018
-
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Journal of the American College of Cardiology, Vol. 71, Núm. 23, pp. 2628-2639
-
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
Journal of the American College of Cardiology, Vol. 71, Núm. 22, pp. 2497-2506
-
Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: A cohort study in the Health Improvement Network in the UK
BMJ Open, Vol. 8, Núm. 1
2017
-
Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK
European Journal of Preventive Cardiology, Vol. 24, Núm. 18, pp. 1927-1937
2016
-
Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: An observational cohort study
Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 3, pp. 427-437